Tongkat Ali and Fadogia Agrestis: The Evidence-Based Guide to Natural TRT Support

Why Testosterone Optimisation Matters

Testosterone declines approximately 1–2% per year after age 30 in men, with significant individual variation. Suboptimal testosterone is associated with reduced muscle mass, increased adiposity, decreased libido, impaired cognitive function, and reduced motivation and wellbeing.

Clinical hypogonadism (total testosterone <300ng/dl) requires medical evaluation. But the large range between clinical hypogonadism and optimal levels (600–900ng/dl) represents substantial territory where lifestyle and evidence-based supplementation can meaningfully improve function without medical intervention.

Tongkat Ali: The Evidence-Based Option

Tongkat Ali (Eurycoma longifolia, Long Jack) is a Malaysian shrub with millennia of traditional use for male sexual health. The bioactive compounds are eurycomalactones, quassinoids, and various alkaloids.

Mechanism: Tongkat Ali works through at least two documented pathways:

1. SHBG reduction — Sex hormone-binding globulin binds testosterone in blood, making it biologically unavailable. Reducing SHBG increases free (biologically active) testosterone without necessarily changing total testosterone.
2. LH stimulation — Some evidence for mild luteinising hormone upregulation, which drives Leydig cell testosterone synthesis.

Human evidence: A 2012 RCT by Tambi et al. enrolled 76 men with late-onset hypogonadism and randomised them to 200mg Tongkat Ali standardised extract daily for 1 month. Free testosterone increased by 37%, with significant improvements in fatigue scores and libido. ^[]

A separate study in 63 moderately stressed adults found Tongkat Ali supplementation for 4 weeks produced significant improvements in salivary testosterone (37% increase), cortisol reduction (16%), and stress hormone ratios. ^[]

Fadogia Agrestis: The Podcast Compound

Fadogia Agrestis has become a staple of testosterone-focused podcasts and supplement stacks. The rodent data is genuinely interesting: Fadogia Agrestis extract appears to stimulate testosterone production via LH-like signalling on Leydig cells. Rodent studies showed significant testosterone increases within weeks.

The problems:

1. No human clinical trials. Zero. The evidence base consists entirely of rodent studies — most from a single research group.
2. Dose-dependent testicular toxicity in rodents. Higher doses in rat studies produced histological changes in testicular tissue. The therapeutic window between efficacy and toxicity in humans is unknown.
3. Mechanism not fully characterised. The active compounds and their specific receptor interactions have not been identified.

Honest assessment: Fadogia Agrestis could be valuable or harmful — current evidence cannot distinguish between these possibilities in humans. The popularity is driven by endorsement rather than clinical data.

The Evidence-Based Testosterone Stack

Rather than Fadogia Agrestis, the evidence-based components for natural testosterone support are:

Tongkat Ali 200–400mg/day (standardised to 1% eurycomanone): LH support + SHBG reduction.

Zinc 25–30mg/day (bisglycinate): Essential cofactor for testosterone synthesis. Zinc deficiency directly impairs testosterone production; correction restores levels. ^[] Avoid zinc supplementation in those not deficient.

Ashwagandha KSM-66 600mg/day: Cortisol reduction indirectly raises testosterone by reducing the cortisol-testosterone antagonism. RCT evidence for testosterone improvement via stress axis normalisation.

Vitamin D3 2000–5000IU/day: Testosterone synthesis enzymes are vitamin D-dependent. Deficiency is strongly associated with hypogonadism; correction improves testosterone in deficient individuals.

This stack addresses testosterone from upstream (cortisol management), synthesis (zinc, vitamin D), and bioavailability (SHBG reduction via Tongkat Ali) angles — with genuine human evidence for each component.